Agilent Technologies (A) has been active on the product front, unveiling its SureSelect Cancer Research Pan Heme NGS panel and the 5987A GC/MS detector with GC Assist and updated MassHunter 14 software.
Agilent Technologies shares trade at US$173.96, with a 1-day share price return of 0.55% and a 90-day share price return of 17.12%. The year-to-date share price return of 26.10% and 3-year total shareholder return of 57.21% point to momentum building around the story these new product launches support.
Scan other lab and cancer research players showing similar momentum and product pipelines through our curated list of 20 high quality undiscovered gems
Agilent Technologies now trades only a few percent below the average analyst target while sitting well above some intrinsic value estimates. With the price already running hard, where does fair value really line up in that spread?
Agilent Technologies is trading at $173.96 against the analyst consensus Narrative fair value of $181.05, which implies a small discount based on forecasts compiled in the analyst consensus Narrative on Simply Wall St.
The Ignite operating model continues to roll through Agilent Technologies, with management now attributing more than 100 basis points of expected FY26 operating margin expansion and about 200 basis points of strategic pricing benefit per quarter to this system. This can support net margin and EPS growth if it keeps offsetting inflation, tariffs and new capacity ramp costs.
See why 39 investors see Agilent Technologies as 4% undervalued.
Result: Fair Value of $181.05 (UNDERVALUED)
Still, renewed tariff pressure and a weaker Academia and Government funding backdrop could challenge the Ignite margin story and unsettle the current Agilent Technologies narrative.
Find out about the key risks to this Agilent Technologies narrative.
The consensus narrative tags Agilent Technologies as about 4% undervalued on future earnings, yet the SWS DCF model tells a very different story. On that cash flow view, Agilent Technologies at $173.96 sits above an intrinsic value estimate of $130.88, which screens as overvalued. Which lens should carry more weight when you judge the risk in today’s price?
To see how that calculation is built and what would need to change for the gap to close, take a closer look at the Look into how the SWS DCF model arrives at its fair value..
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Agilent Technologies for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 32 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Sentiment around Agilent Technologies is split, which makes this a good moment to move fast, review the underlying numbers yourself and pressure test every assumption against your own risk tolerance. To see what optimistic investors are focusing on, start with the 3 key rewards.
Do not stop with Agilent Technologies. Broaden your watchlist now with focused stock ideas that match your risk profile and income goals before any potential changes in the market are reflected in prices.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com